Stock Scorecard



Stock Summary for KalVista Pharmaceuticals Inc (KALV) - $11.07 as of 3/28/2024 2:32:30 PM EST

Total Score

8 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for KALV

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for KALV

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for KALV

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for KALV

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for KALV

Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday - Citigroup ( NYSE:C ) 2/14/2024 12:49:00 PM
Why Is KalVista Pharmaceuticals Stock Trading Lower Today? - KalVista Pharma ( NASDAQ:KALV ) 2/13/2024 4:02:00 PM
Insiders Buying Monro And 3 Other Stocks - KalVista Pharma ( NASDAQ:KALV ) , Lee Enterprises ( NASDAQ:LEE ) 2/9/2024 1:35:00 PM
$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying - Cleveland-Cliffs ( NYSE:CLF ) , ArriVent BioPharma ( NASDAQ:AVBP ) 2/2/2024 1:56:00 PM
Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying - KalVista Pharma ( NASDAQ:KALV ) , FB Financial ( NYSE:FBK ) 1/30/2024 11:52:00 AM
$230M Bet On Talos Energy? Check Out These 4 Stocks Insiders Are Buying - KalVista Pharma ( NASDAQ:KALV ) , Amrep ( NYSE:AXR ) 1/22/2024 11:41:00 AM
Insiders Buying Dorian LPG And 2 Other Stocks - Avadel Pharmaceuticals ( NASDAQ:AVDL ) , KalVista Pharma ( NASDAQ:KALV ) 1/17/2024 11:23:00 AM
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks - KalVista Pharma ( NASDAQ:KALV ) , Avid Bioservices ( NASDAQ:CDMO ) 1/11/2024 11:40:00 AM
$6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying - KalVista Pharma ( NASDAQ:KALV ) , NB Bancorp ( NASDAQ:NBBK ) 1/8/2024 12:13:00 PM
Around $2.4M Bet On HighPeak Energy? Check Out These 4 Stocks Insiders Are Buying - HighPeak Energy ( NASDAQ:HPK ) , KalVista Pharma ( NASDAQ:KALV ) 1/2/2024 2:00:00 PM

Financial Details for KALV

Company Overview

Ticker KALV
Company Name KalVista Pharmaceuticals Inc
Country USA
Description KalVista Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, discovers, develops, and markets small-molecule protease inhibitors for illnesses with unmet needs. The company is headquartered in Cambridge, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 1/31/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 11.07
Last Day Price Updated 3/28/2024 2:32:30 PM EST
Last Day Volume 0
Average Daily Volume 1,113,380
52-Week High 16.88
52-Week Low 7.21
Last Price to 52 Week Low 53.54%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -6.00
Free Cash Flow Ratio 6.18
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 5.44
Total Cash Per Share 1.79
Book Value Per Share Most Recent Quarter 2.56
Price to Book Ratio 5.27
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 107.42
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 42,188,300
Market Capitalization 467,024,481
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -12.83%
Reported EPS 12 Trailing Months -3.12
Reported EPS Past Year -2.38
Reported EPS Prior Year -3.36
Net Income Twelve Trailing Months -108,300,000
Net Income Past Year -92,907,000
Net Income Prior Year -82,339,000
Quarterly Revenue Growth YOY 30.70%
5-Year Revenue Growth -42.71%

Balance Sheet

Total Cash Most Recent Quarter 75,586,000
Total Cash Past Year 149,375,000
Total Cash Prior Year 166,202,000
Net Cash Position Most Recent Quarter 75,586,000
Net Cash Position Past Year 149,375,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 161,025,000
Total Stockholder Equity Prior Year 185,093,000
Total Stockholder Equity Most Recent Quarter 88,583,000

Options

Put/Call Ratio 2.69
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.59
MACD Signal -0.43
20-Day Bollinger Lower Band 7.40
20-Day Bollinger Middle Band 12.00
20-Day Bollinger Upper Band 16.60
Beta 0.90
RSI 33.89
50-Day SMA 10.53
200-Day SMA 14.12

System

Modified 3/28/2024 11:17:51 PM EST